Everly Health Stock

everlywell.comHealthcareFounded: 2015Funding to Date: $674.09MM

Everyly Health created a new kind of healthcare experience that’s centered around people. Their infrastructure guides the full testing experience with the support of a national clinician network that’s composed of hundreds of physicians, nurses, genetic counselors, PharmDs, and member care specialists. This company was founded by Julia Cheek in 2015 and is headquartered in Austin, TX.

Register for Details

For more details on financing and valuation for Everly Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Everly Health.

Register Today

Team

Management Team

Julia Cheek
Founder & Chief Executive Officer
Nick Parker
Chief Technology Officer
Jenifer Dasho
Chief Marketing Officer
Stace Houk
Chief People Officer
Dana Underwood
Chief Product Officer
Chris Bishko
Chief Financial Officer
Matthew Carroll
Executive Vice President & General Manager

Board Members

Michael Smerklo
Next Coast Ventures
Eric Kim
Goodwater Capital
Garheng Kong Ph.D
HealthQuest Capital
Judith Rodin Ph.D
Portfolia

Other companies like Everly Health in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B

News

Everlywell, a Texas-based producer of home tests for COVID-19 and other diseases and conditions, has raised $75 million on top of a recent $175 million round.
At-home health testing kit startup Everlywell has raised $75 million, following the close of the $175 million Series D it announced in December. The new funding comes from HealthQuest Capital, and sees the fund’s founder and managing partner Dr. Garheng Kong join the company’s board of …
With the new investment, CEO Julia Cheek confirmed the company’s valuation at $1.3 billion.